ketoconazole has been researched along with Angiogenesis, Pathologic in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esposito, G | 1 |
| Gigli, S | 1 |
| Seguella, L | 1 |
| Nobile, N | 1 |
| D'Alessandro, A | 1 |
| Pesce, M | 1 |
| Capoccia, E | 1 |
| Steardo, L | 1 |
| Cirillo, C | 1 |
| Cuomo, R | 1 |
| Sarnelli, G | 1 |
1 other study available for ketoconazole and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
Topics: Anti-Bacterial Agents; Caco-2 Cells; Cell Movement; Cell Proliferation; Colonic Neoplasms; Gene Expr | 2016 |